Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1780400

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1780400

EU5 Cardiac Disease Market Outlook to 2033 - Cardiac Marker Tests

PUBLISHED:
PAGES: 84 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5995
PDF (Site License)
USD 11990
PDF (Global License)
USD 17985

Add to Cart

GlobalData's "EU5 Cardiac Disease Market Outlook to 2033" is a comprehensive databook report, covering key market data on the EU5 Cardiac Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Marker Tests

The EU5 Cardiac Disease Market report provides key information and data on -

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Cardiac Disease Market.
  • Global corporate-level profiles of key companies operating within the EU5 Cardiac Disease Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

EU5 Cardiac Disease is segmented as follows -

  • Cardiac Marker Tests

Reasons to Buy

The EU5 Cardiac Disease Market report helps you to develop -

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Product Code: GDME20407CRDB

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Cardiac Disease Market Segmentation
  • 2.3 Definitions of Markets Covered in the Report

3 Cardiac Disease Market, EU5

  • 3.1 Cardiac Disease Market, EU5, Revenue ($m), 2018-2033
  • 3.2 Cardiac Disease Market, EU5, Revenue ($m), 2018-2033
  • 3.3 Cardiac Disease Market, EU5, Volume (Units), 2018-2033
  • 3.4 Cardiac Disease Market, EU5, Volume (Units), 2018-2033
  • 3.5 Cardiac Disease Market, EU5, Company Share by Revenue ($m), 2024

4 Cardiac Disease Market, France

  • 4.1 Cardiac Disease Market, France, Revenue ($m), 2018-2033
    • 4.1.1 Cardiac Marker Tests Market, France, Revenue ($m), by Segment, 2018-2033
  • 4.2 Cardiac Disease Market, France, Volume (Units), 2018-2033
    • 4.2.1 Cardiac Marker Tests Market, France, Volume (Units), by Segment, 2018-2033
  • 4.3 Cardiac Disease Market, France, Average Price ($), 2018-2033
  • 4.4 Cardiac Disease Market, France, Company Share by Revenue ($m), 2024

5 Cardiac Disease Market, Italy

  • 5.1 Cardiac Disease Market, Italy, Revenue ($m), 2018-2033
    • 5.1.1 Cardiac Marker Tests Market, Italy, Revenue ($m), by Segment, 2018-2033
  • 5.2 Cardiac Disease Market, Italy, Volume (Units), 2018-2033
    • 5.2.1 Cardiac Marker Tests Market, Italy, Volume (Units), by Segment, 2018-2033
  • 5.3 Cardiac Disease Market, Italy, Average Price ($), 2018-2033
  • 5.4 Cardiac Disease Market, Italy, Company Share by Revenue ($m),2024

6 Cardiac Disease Market, Spain

  • 6.1 Cardiac Disease Market, Spain, Revenue ($m), 2018-2033
    • 6.1.1 Cardiac Marker Tests Market, Spain, Revenue ($m), by Segment, 2018-2033
  • 6.2 Cardiac Disease Market, Spain, Volume (Units), 2018-2033
    • 6.2.1 Cardiac Marker Tests Market, Spain, Volume (Units), by Segment, 2018-2033
  • 6.3 Cardiac Disease Market, Spain, Average Price ($), 2018-2033
  • 6.4 Cardiac Disease Market, Spain, Company Share by Revenue ($m), 2024

7 Cardiac Disease Market, Germany

  • 7.1 Cardiac Disease Market, Germany, Revenue ($m), 2018-2033
    • 7.1.1 Cardiac Marker Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
  • 7.2 Cardiac Disease Market, Germany, Volume (Units), 2018-2033
    • 7.2.1 Cardiac Marker Tests Market, Germany, Volume (Units), by Segment, 2018-2033
  • 7.3 Cardiac Disease Market, Germany, Average Price ($), 2018-2033
  • 7.4 Cardiac Disease Market, Germany, Company Share by Revenue ($m), 2024

8 Cardiac Disease Market, United Kingdom

  • 8.1 Cardiac Disease Market, United Kingdom, Revenue ($m), 2018-2033
    • 8.1.1 Cardiac Marker Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
  • 8.2 Cardiac Disease Market, United Kingdom, Volume (Units), 2018-2033
    • 8.2.1 Cardiac Marker Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033
  • 8.3 Cardiac Disease Market, United Kingdom, Average Price ($), 2018-2033
  • 8.4 Cardiac Disease Market, United Kingdom, Company Share by Revenue ($m), 2024

9 Overview of Key Companies in EU5 Cardiac Disease Market

  • 9.1 Abbott Laboratories
    • 9.1.1 Company Overview
  • 9.2 F. Hoffmann-La Roche Ltd
    • 9.2.1 Company Overview
  • 9.3 Siemens Healthineers AG
    • 9.3.1 Company Overview
  • 9.4 Beckman Coulter Inc
    • 9.4.1 Company Overview
  • 9.5 Quidel Corp
    • 9.5.1 Company Overview
  • 9.6 bioMerieux SA
    • 9.6.1 Company Overview

10 Cardiac Disease Market Pipeline Products

11 Recent Developments

  • 11.1 Corporate Communications
    • 11.1.1 Sep 30, 2024: EDX Medical Group: Annual General Meeting Results
  • 11.2 Financial Announcements
    • 11.2.1 Sep 04, 2024: EDX Medical Group Releases Annual Report and Financial Statements for the Period Ending March 31, 2024
  • 11.3 Other Significant Developments
    • 11.3.1 Oct 09, 2024: Heart Health for All: How We Can Improve Access to Cardiac Care around the Globe
    • 11.3.2 Sep 20, 2024: Funding Supports Neuranics' Groundbreaking AI Technology for Remote Heart Health Monitoring
  • 11.4 Product News
    • 11.4.1 Apr 28, 2025: Simple Blood Test Could Better Predict Heart Disease Risk
    • 11.4.2 Oct 30, 2024: Market Report Highlights Opportunity for Consumer Wearables to Enhance Accuracy and Build Trust with Providers
    • 11.4.3 Jul 22, 2024: Accelerating Genomics through Automated RNA Sequencing
  • 11.5 Strategy And Business Planning
    • 11.5.1 Feb 13, 2025: Hemolens Diagnostics Expands International Cooperation in the Field of in Silico Medical Technology
    • 11.5.2 Sep 20, 2024: Funding Supports Neuranics' Groundbreaking AI Technology for Remote Heart Health Monitoring

12 Appendix

  • 12.1 Research Methodology
    • 12.1.1 Coverage
    • 12.1.2 Secondary Research
    • 12.1.3 Primary Research
    • 12.1.4 Market Modeling and Forecasting
    • 12.1.5 Company Share Analysis
    • 12.1.6 Benchmarking
  • 12.2 GlobalData Consulting
  • 12.3 Contact Us
  • 12.4 Disclaimer
Product Code: GDME20407CRDB

List of Table

List of Tables

  • Table 1: Cardiac Disease Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2018-2033
  • Table 2: Cardiac Disease Market, EU5, Revenue ($m), USD Constant, 2018-2033
  • Table 3: Cardiac Disease Market, EU5, Volume (Units), 2018-2033
  • Table 4: Cardiac Disease Market, EU5, Volume (Units), 2018-2033
  • Table 5: Cardiac Disease Market, EU5, Company Share by Revenue ($m), 2024
  • Table 6: Cardiac Disease Market, France, Revenue ($m), USD Constant, 2018-2033
  • Table 7: Cardiac Marker Tests Market, France, Revenue ($m), USD Constant, 2018-2033
  • Table 8: Cardiac Disease Market, France, Volume (Units), 2018-2033
  • Table 9: Cardiac Marker Tests Market, France, Volume (Units), 2018-2033
  • Table 10: Cardiac Disease Market, France, Average Price ($), 2018-2033
  • Table 11: Cardiac Disease Market, France, Company Share by Revenue ($m), 2024
  • Table 12: Cardiac Disease Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Table 13: Cardiac Marker Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Table 14: Cardiac Disease Market, Italy, Volume (Units), 2018-2033
  • Table 15: Cardiac Marker Tests Market, Italy, Volume (Units), 2018-2033
  • Table 16: Cardiac Disease Market, Italy, Average Price ($), 2018-2033
  • Table 17: Cardiac Disease Market, Italy, Company Share by Revenue ($m), 2024
  • Table 18: Cardiac Disease Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Table 19: Cardiac Marker Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Table 20: Cardiac Disease Market, Spain, Volume (Units), 2018-2033
  • Table 21: Cardiac Marker Tests Market, Spain, Volume (Units), 2018-2033
  • Table 22: Cardiac Disease Market, Spain, Average Price ($), 2018-2033
  • Table 23: Cardiac Disease Market, Spain, Company Share by Revenue ($m), 2024
  • Table 24: Cardiac Disease Market, Germany, Revenue ($m), USD Constant, 2018-2033
  • Table 25: Cardiac Marker Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
  • Table 26: Cardiac Disease Market, Germany, Volume (Units), 2018-2033
  • Table 27: Cardiac Marker Tests Market, Germany, Volume (Units), 2018-2033
  • Table 28: Cardiac Disease Market, Germany, Average Price ($), 2018-2033
  • Table 29: Cardiac Disease Market, Germany, Company Share by Revenue ($m), 2024
  • Table 30: Cardiac Disease Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Table 31: Cardiac Marker Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Table 32: Cardiac Disease Market, United Kingdom, Volume (Units), 2018-2033
  • Table 33: Cardiac Marker Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Table 34: Cardiac Disease Market, United Kingdom, Average Price ($), 2018-2033
  • Table 35: Cardiac Disease Market, United Kingdom, Company Share by Revenue ($m), 2024
  • Table 41: Cardiac Disease Market Pipeline Products
  • Table 13: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

List of Figure

List of Figures

  • Figure 1: Cardiac Disease Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2018-2033
  • Figure 2: Cardiac Disease Market, EU5, Revenue ($m), USD Constant, 2018-2033
  • Figure 3: Cardiac Disease Market, EU5, Volume (Units), 2018-2033
  • Figure 4: Cardiac Disease Market, EU5, Volume (Units), 2018-2033
  • Figure 5: Cardiac Disease Market, EU5, Company Share (%), 2024
  • Figure 6: Cardiac Disease Market, France, Revenue ($m), USD Constant, 2018-2033
  • Figure 7: Cardiac Marker Tests Market, France, Revenue ($m), USD Constant, 2018-2033
  • Figure 8: Cardiac Disease Market, France, Volume (Units), 2018-2033
  • Figure 9: Cardiac Marker Tests Market, France, Volume (Units), 2018-2033
  • Figure 10: Cardiac Disease Market, France, Company Share (%), 2024
  • Figure 11: Cardiac Disease Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Figure 12: Cardiac Marker Tests Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Figure 13: Cardiac Disease Market, Italy, Volume (Units), 2018-2033
  • Figure 14: Cardiac Marker Tests Market, Italy, Volume (Units), 2018-2033
  • Figure 15: Cardiac Disease Market, Italy, Company Share (%), 2024
  • Figure 16: Cardiac Disease Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Figure 17: Cardiac Marker Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Figure 18: Cardiac Disease Market, Spain, Volume (Units), 2018-2033
  • Figure 19: Cardiac Marker Tests Market, Spain, Volume (Units), 2018-2033
  • Figure 20: Cardiac Disease Market, Spain, Company Share (%), 2024
  • Figure 21: Cardiac Disease Market, Germany, Revenue ($m), USD Constant, 2018-2033
  • Figure 22: Cardiac Marker Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
  • Figure 23: Cardiac Disease Market, Germany, Volume (Units), 2018-2033
  • Figure 24: Cardiac Marker Tests Market, Germany, Volume (Units), 2018-2033
  • Figure 25: Cardiac Disease Market, Germany, Company Share (%), 2024
  • Figure 26: Cardiac Disease Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Figure 27: Cardiac Marker Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Figure 28: Cardiac Disease Market, United Kingdom, Volume (Units), 2018-2033
  • Figure 29: Cardiac Marker Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Figure 30: Cardiac Disease Market, United Kingdom, Company Share (%), 2024
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!